Werewolf Therapeutics Ownership 2024 | Who Owns Werewolf Therapeutics Now?
Institutional Ownership
88.19%
Insider Ownership
6.27%
Retail Ownership
5.54%
Institutional Holders
63.00
Werewolf Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 16.80% | 0.06% | 6,144,881 | - | - | 39,818,829 | Mar 31, 2024 |
| MPM ASSET MANAGEMENT LLC | 11.71% | 11.32% | 4,284,172 | - | - | 27,761,435 | Mar 31, 2024 |
| PFM HEALTH SCIENCES, LP | 8.22% | 0.92% | 3,006,734 | -461,443 | -13.31% | 19,483,636 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.21% | 0.04% | 3,000,594 | -33,661 | -1.11% | 19,443,849 | Mar 31, 2024 |
| BIOIMPACT CAPITAL LLC | 6.53% | 2.49% | 2,388,011 | - | - | 15,474,311 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 5.14% | 0.00% | 1,881,113 | -214,968 | -10.26% | 12,189,612,000 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 4.62% | 0.01% | 1,688,054 | 1,688,054 | 100.00% | 10,921,709 | Mar 31, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 4.43% | 0.31% | 1,621,034 | -314,323 | -16.24% | 10,504,300 | Mar 31, 2024 |
| VANGUARD GROUP INC | 3.03% | 0.00% | 1,107,347 | 233,909 | 26.78% | 7,175,609 | Mar 31, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 2.43% | 0.68% | 890,000 | 890,000 | 100.00% | 5,767,200 | Mar 31, 2024 |
| EAGLE HEALTH INVESTMENTS LP | 1.91% | 0.84% | 700,000 | 700,000 | 100.00% | 4,536,000 | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.71% | 0.57% | 626,810 | - | - | 4,061,729 | Mar 31, 2024 |
| DC FUNDS, LP | 1.61% | 36.89% | 589,102 | - | - | 3,817,381 | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 1.56% | 0.03% | 571,466 | 571,466 | 100.00% | 3,703,100 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.55% | 0.00% | 565,417 | 121,058 | 27.24% | 3,663,902 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.71% | 0.00% | 259,680 | 65,372 | 33.64% | 1,683,059 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.68% | 0.00% | 247,600 | 70,300 | 39.65% | 1,604,448 | Mar 31, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.64% | 0.01% | 235,705 | -200,000 | -45.90% | 1,527,368 | Mar 31, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.55% | 0.01% | 201,236 | 122,023 | 154.04% | 1,304,009 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.51% | 0.00% | 185,059 | 38,323 | 26.12% | 1,199,182 | Mar 31, 2024 |
Werewolf Therapeutics's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 16.80% of the company's total share outstanding, currently valued at $39.82M. The top 10 institutional shareholders own together 71.13% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DC FUNDS, LP | 1.61% | 36.89% | 589,102 | - | - | 3,817,381 | Mar 31, 2024 |
| MPM ASSET MANAGEMENT LLC | 11.71% | 11.32% | 4,284,172 | - | - | 27,761,435 | Mar 31, 2024 |
| BIOIMPACT CAPITAL LLC | 6.53% | 2.49% | 2,388,011 | - | - | 15,474,311 | Mar 31, 2024 |
| PFM HEALTH SCIENCES, LP | 8.22% | 0.92% | 3,006,734 | -461,443 | -13.31% | 19,483,636 | Mar 31, 2024 |
| EAGLE HEALTH INVESTMENTS LP | 1.91% | 0.84% | 700,000 | 700,000 | 100.00% | 4,536,000 | Mar 31, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 2.43% | 0.68% | 890,000 | 890,000 | 100.00% | 5,767,200 | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.71% | 0.57% | 626,810 | - | - | 4,061,729 | Mar 31, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 4.43% | 0.31% | 1,621,034 | -314,323 | -16.24% | 10,504,300 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 16.80% | 0.06% | 6,144,881 | - | - | 39,818,829 | Mar 31, 2024 |
| DENALI ADVISORS LLC | 0.07% | 0.05% | 26,600 | 26,600 | 100.00% | 172,368 | Mar 31, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.06% | 0.04% | 23,264 | 23,264 | 100.00% | 150,751 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.21% | 0.04% | 3,000,594 | -33,661 | -1.11% | 19,443,849 | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 1.56% | 0.03% | 571,466 | 571,466 | 100.00% | 3,703,100 | Mar 31, 2024 |
| FINANCIAL PERSPECTIVES, INC | 0.02% | 0.02% | 6,750 | - | - | 43,740 | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.23% | 0.01% | 85,086 | - | - | 551,357 | Mar 31, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.55% | 0.01% | 201,236 | 122,023 | 154.04% | 1,304,009 | Mar 31, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.64% | 0.01% | 235,705 | -200,000 | -45.90% | 1,527,368 | Mar 31, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.04% | 0.01% | 14,154 | 14,154 | 100.00% | 91,718 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 4.62% | 0.01% | 1,688,054 | 1,688,054 | 100.00% | 10,921,709 | Mar 31, 2024 |
| CERTUITY, LLC | 0.03% | 0.01% | 10,000 | - | - | 64,800 | Mar 31, 2024 |
The largest Werewolf Therapeutics shareholder by % of total assets is DC FUNDS, LP. The company owns 589.10K shares of Werewolf Therapeutics (HOWL), representing 36.89% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 4.62% | 0.01% | 1,688,054 | 1,688,054 | 100.00% | 10,921,709 | Mar 31, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 2.43% | 0.68% | 890,000 | 890,000 | 100.00% | 5,767,200 | Mar 31, 2024 |
| EAGLE HEALTH INVESTMENTS LP | 1.91% | 0.84% | 700,000 | 700,000 | 100.00% | 4,536,000 | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 1.56% | 0.03% | 571,466 | 571,466 | 100.00% | 3,703,100 | Mar 31, 2024 |
| VANGUARD GROUP INC | 3.03% | 0.00% | 1,107,347 | 233,909 | 26.78% | 7,175,609 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.48% | 0.00% | 175,798 | 175,798 | 100.00% | 1,139,171 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.47% | 0.00% | 172,794 | 172,794 | 100.00% | 1,119,705 | Mar 31, 2024 |
| JANE STREET GROUP, LLC | 0.43% | 0.00% | 157,226 | 142,739 | 985.29% | 1,018,824 | Mar 31, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 0.55% | 0.01% | 201,236 | 122,023 | 154.04% | 1,304,009 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.55% | 0.00% | 565,417 | 121,058 | 27.24% | 3,663,902 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.32% | 0.00% | 117,013 | 114,629 | 4808.26% | 758,244 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.47% | 0.00% | 172,883 | 94,212 | 119.75% | 1,119,000 | Mar 31, 2024 |
| BLACKROCK INC. | 0.45% | - | 164,792 | 92,564 | 128.16% | 1,067,852 | Mar 31, 2024 |
| MAN GROUP PLC | 0.22% | 0.00% | 79,639 | 79,639 | 100.00% | 516,061 | Mar 31, 2024 |
| CITIGROUP INC | 0.20% | 0.00% | 71,556 | 71,556 | 100.00% | 463,683 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.19% | - | 71,184 | 71,101 | 85663.86% | 461,272 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.68% | 0.00% | 247,600 | 70,300 | 39.65% | 1,604,448 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.71% | 0.00% | 259,680 | 65,372 | 33.64% | 1,683,059 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.31% | 0.00% | 111,625 | 48,702 | 77.40% | 723,329 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.11% | 0.00% | 40,649 | 40,649 | 100.00% | 263,406 | Mar 31, 2024 |
As of Mar 31 2024, Werewolf Therapeutics's largest institutional buyer is JANUS HENDERSON GROUP PLC. The company purchased 1.69M stocks of HOWL, valued at $10.92M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PFM HEALTH SCIENCES, LP | 8.22% | 0.92% | 3,006,734 | -461,443 | -13.31% | 19,483,636 | Mar 31, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 4.43% | 0.31% | 1,621,034 | -314,323 | -16.24% | 10,504,300 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 5.14% | 0.00% | 1,881,113 | -214,968 | -10.26% | 12,189,612,000 | Mar 31, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.64% | 0.01% | 235,705 | -200,000 | -45.90% | 1,527,368 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.21% | 0.04% | 3,000,594 | -33,661 | -1.11% | 19,443,849 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.23% | 0.00% | 84,200 | -23,306 | -21.68% | 546,000 | Mar 31, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -22,472 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.01% | - | 3,073 | -18,449 | -85.72% | 19,913 | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -15,400 | -100.00% | - | Mar 31, 2024 |
| HBK SORCE ADVISORY LLC | 0.04% | 0.00% | 13,227 | -13,227 | -50.00% | 85,711 | Mar 31, 2024 |
| STATE STREET CORP | 0.19% | - | 71,168 | -12,300 | -14.74% | 461,169 | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 202 | -5,496 | -96.45% | 1,000 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.01% | - | 2,400 | -1,300 | -35.14% | 15,552 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.13% | 0.00% | 48,502 | -1,146 | -2.31% | 314,293 | Mar 31, 2024 |
| UBS GROUP AG | 0.00% | - | 37 | -963 | -96.30% | 240 | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -100 | -100.00% | - | Mar 31, 2024 |
| DC FUNDS, LP | 1.61% | 36.89% | 589,102 | - | - | 3,817,381 | Mar 31, 2024 |
| MPM ASSET MANAGEMENT LLC | 11.71% | 11.32% | 4,284,172 | - | - | 27,761,435 | Mar 31, 2024 |
| BIOIMPACT CAPITAL LLC | 6.53% | 2.49% | 2,388,011 | - | - | 15,474,311 | Mar 31, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 1.71% | 0.57% | 626,810 | - | - | 4,061,729 | Mar 31, 2024 |
As of Mar 31 2024, Werewolf Therapeutics's biggest institutional seller is PFM HEALTH SCIENCES, LP. The company sold -0.46M shares of HOWL, valued at $19.48M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 4.62% | 0.01% | 1,688,054 | 1,688,054 | 100.00% | 10,921,709 | Mar 31, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 2.43% | 0.68% | 890,000 | 890,000 | 100.00% | 5,767,200 | Mar 31, 2024 |
| EAGLE HEALTH INVESTMENTS LP | 1.91% | 0.84% | 700,000 | 700,000 | 100.00% | 4,536,000 | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 1.56% | 0.03% | 571,466 | 571,466 | 100.00% | 3,703,100 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.48% | 0.00% | 175,798 | 175,798 | 100.00% | 1,139,171 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.47% | 0.00% | 172,794 | 172,794 | 100.00% | 1,119,705 | Mar 31, 2024 |
| MAN GROUP PLC | 0.22% | 0.00% | 79,639 | 79,639 | 100.00% | 516,061 | Mar 31, 2024 |
| CITIGROUP INC | 0.20% | 0.00% | 71,556 | 71,556 | 100.00% | 463,683 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.11% | 0.00% | 40,649 | 40,649 | 100.00% | 263,406 | Mar 31, 2024 |
| HRT FINANCIAL LP | 0.10% | 0.00% | 37,628 | 37,628 | 100.00% | 243,000 | Mar 31, 2024 |
| ROYCE & ASSOCIATES LP | 0.10% | 0.00% | 37,321 | 37,321 | 100.00% | 241,840 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.08% | - | 27,700 | 27,700 | 100.00% | 179,496 | Mar 31, 2024 |
| DENALI ADVISORS LLC | 0.07% | 0.05% | 26,600 | 26,600 | 100.00% | 172,368 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.07% | 0.00% | 26,284 | 26,284 | 100.00% | 170,320 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.07% | 0.00% | 25,240 | 25,240 | 100.00% | 164,000 | Mar 31, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.07% | 0.00% | 24,978 | 24,978 | 100.00% | 161,857 | Mar 31, 2024 |
| SQUAREPOINT OPS LLC | 0.07% | 0.00% | 24,594 | 24,594 | 100.00% | 159,369 | Mar 31, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.06% | 0.00% | 23,659 | 23,659 | 100.00% | 153,310 | Mar 31, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.06% | 0.04% | 23,264 | 23,264 | 100.00% | 150,751 | Mar 31, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.06% | 0.00% | 23,048 | 23,048 | 100.00% | 149,351 | Mar 31, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.05% | 0.00% | 18,910 | 18,910 | 100.00% | 122,537 | Mar 31, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.04% | 0.01% | 14,154 | 14,154 | 100.00% | 91,718 | Mar 31, 2024 |
| OMERS ADMINISTRATION CORP | 0.03% | 0.00% | 10,800 | 10,800 | 100.00% | 69,984 | Mar 31, 2024 |
| BARCLAYS PLC | 0.01% | - | 1,878 | 1,878 | 100.00% | 12,000 | Mar 31, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 940 | 940 | 100.00% | 6 | Mar 31, 2024 |
Werewolf Therapeutics's largest new institutional shareholder by number of shares is JANUS HENDERSON GROUP PLC, purchased 1.69M shares, valued at $10.92M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -22,472 | -100.00% | - | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -15,400 | -100.00% | - | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -100 | -100.00% | - | Mar 31, 2024 |
Werewolf Therapeutics's largest sold out institutional shareholder by shares sold is LIGHTHOUSE INVESTMENT PARTNERS, LLC, sold -22.47K shares, valued at -, as of undefined.
Werewolf Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.03% | 79,586 | -10,425 | -11.58% | Dec 29, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,104 | - | - | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 748 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 1,113,387 | 573,221 | 106.12% | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 198,743 | 30,605 | 18.20% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,041 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 10,505 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 10,282 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,267 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 7,424 | - | - | Dec 31, 2023 |
| RUSSELL INVESTMENT CO | 0.00% | 71,565 | - | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 487 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 12,075 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 752 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 199,603 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 5,400 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 565 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 252 | - | - | Dec 31, 2023 |
| Dimensional ETF Trust | 0.00% | 24,966 | 10,706 | 75.08% | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 150 | - | - | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 6,136 | 6,136 | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 888 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 87,421 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 37,999 | 7,981 | 26.59% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 139 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 9,788 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 2,100 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 900 | - | - | Dec 29, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 153 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 26 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,865 | -17,335 | -85.82% | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 14,596 | - | - | Dec 29, 2023 |
| Blackstone Alternative Investment Funds | 0.00% | 1,357 | 1,357 | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,012 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 2,484 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,912 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 6,900 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 11,421 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 3,206 | -545 | -14.53% | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 43,463 | - | - | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,870 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,614 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 86 | - | - | Dec 31, 2023 |
| BLACKROCK FUNDS | 0.00% | 3,999 | - | - | Feb 29, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,425 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 6,000 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 415 | - | - | Dec 31, 2023 |
Werewolf Therapeutics's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 79.59K shares, compromising 0.03% of its total assets.
Werewolf Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 63 | 50.00% |
| 31 Dec, 23 | 42 | 20.00% |
| 30 Sep, 23 | 35 | -2.78% |
| 30 Jun, 23 | 36 | -2.70% |
| 31 Mar, 23 | 37 | -5.13% |
| 31 Dec, 22 | 39 | - |
| 30 Sep, 22 | 39 | - |
| 30 Jun, 22 | 39 | -18.75% |
| 31 Mar, 22 | 48 | -4.00% |
| 31 Dec, 21 | 50 | 19.05% |
| 30 Sep, 21 | 42 | -6.67% |
| 30 Jun, 21 | 45 | - |
As of 31 Mar 24, 63 institutions are holding Werewolf Therapeutics's shares, representing an increase of 50.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 32,252,027 | 16.62% |
| 31 Dec, 23 | 27,655,222 | 15.79% |
| 30 Sep, 23 | 23,883,269 | -0.67% |
| 30 Jun, 23 | 24,045,139 | 0.04% |
| 31 Mar, 23 | 24,035,818 | 15.05% |
| 31 Dec, 22 | 20,891,705 | -0.31% |
| 30 Sep, 22 | 20,956,655 | 9.88% |
| 30 Jun, 22 | 19,072,004 | 0.27% |
| 31 Mar, 22 | 19,019,822 | -0.57% |
| 31 Dec, 21 | 19,128,922 | 0.64% |
| 30 Sep, 21 | 19,007,950 | -3.80% |
| 30 Jun, 21 | 19,758,285 | - |
Werewolf Therapeutics (HOWL) has 32.25M shares outstanding as of 31 Mar 24, up 16.62% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 88.19% | 1.47% |
| 31 Dec, 23 | 77.57% | 1.72% |
| 30 Sep, 23 | 67.17% | 1.41% |
| 30 Jun, 23 | 69.13% | 1.45% |
| 31 Mar, 23 | 69.10% | 1.32% |
| 31 Dec, 22 | 72.38% | 1.46% |
| 30 Sep, 22 | 70.41% | 1.47% |
| 30 Jun, 22 | 69.31% | 1.44% |
| 31 Mar, 22 | 69.43% | 0.65% |
| 31 Dec, 21 | 103.65% | 2.12% |
| 30 Sep, 21 | 69.91% | 0.56% |
| 30 Jun, 21 | 111.31% | - |
As of 31 Mar 24, Werewolf Therapeutics is held by 88.19% institutional shareholders, representing a 1.47% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 39 | 77.27% |
| 31 Dec, 23 | 22 | 69.23% |
| 30 Sep, 23 | 13 | 8.33% |
| 30 Jun, 23 | 12 | -36.84% |
| 31 Mar, 23 | 19 | - |
| 31 Dec, 22 | 19 | 18.75% |
| 30 Sep, 22 | 16 | -5.88% |
| 30 Jun, 22 | 17 | -22.73% |
| 31 Mar, 22 | 22 | -31.25% |
| 31 Dec, 21 | 32 | 88.24% |
| 30 Sep, 21 | 17 | -62.22% |
| 30 Jun, 21 | 45 | - |
39 institutional shareholders have increased their position in HOWL stock as of 31 Mar 24 compared to 22 in the previous quarter (a 77.27% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 12 | 71.43% |
| 31 Dec, 23 | 7 | 75.00% |
| 30 Sep, 23 | 4 | 33.33% |
| 30 Jun, 23 | 3 | -62.50% |
| 31 Mar, 23 | 8 | -11.11% |
| 31 Dec, 22 | 9 | -18.18% |
| 30 Sep, 22 | 11 | -15.38% |
| 30 Jun, 22 | 13 | -13.33% |
| 31 Mar, 22 | 15 | 114.29% |
| 31 Dec, 21 | 7 | -41.67% |
| 30 Sep, 21 | 12 | - |
| 30 Jun, 21 | - | - |
12 institutional shareholders have reduced their position in HOWL stock as of 31 Mar 24 compared to 7 in the previous quarter (a 71.43% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 63 | 50.00% | 32,252,027 | 16.62% | 88.19% | 1.47% | 39 | 77.27% | 12 | 71.43% |
| 31 Dec, 23 | 42 | 20.00% | 27,655,222 | 15.79% | 77.57% | 1.72% | 22 | 69.23% | 7 | 75.00% |
| 30 Sep, 23 | 35 | -2.78% | 23,883,269 | -0.67% | 67.17% | 1.41% | 13 | 8.33% | 4 | 33.33% |
| 30 Jun, 23 | 36 | -2.70% | 24,045,139 | 0.04% | 69.13% | 1.45% | 12 | -36.84% | 3 | -62.50% |
| 31 Mar, 23 | 37 | -5.13% | 24,035,818 | 15.05% | 69.10% | 1.32% | 19 | - | 8 | -11.11% |
| 31 Dec, 22 | 39 | - | 20,891,705 | -0.31% | 72.38% | 1.46% | 19 | 18.75% | 9 | -18.18% |
| 30 Sep, 22 | 39 | - | 20,956,655 | 9.88% | 70.41% | 1.47% | 16 | -5.88% | 11 | -15.38% |
| 30 Jun, 22 | 39 | -18.75% | 19,072,004 | 0.27% | 69.31% | 1.44% | 17 | -22.73% | 13 | -13.33% |
| 31 Mar, 22 | 48 | -4.00% | 19,019,822 | -0.57% | 69.43% | 0.65% | 22 | -31.25% | 15 | 114.29% |
| 31 Dec, 21 | 50 | 19.05% | 19,128,922 | 0.64% | 103.65% | 2.12% | 32 | 88.24% | 7 | -41.67% |
| 30 Sep, 21 | 42 | -6.67% | 19,007,950 | -3.80% | 69.91% | 0.56% | 17 | -62.22% | 12 | - |
| 30 Jun, 21 | 45 | - | 19,758,285 | - | 111.31% | - | 45 | - | - | - |
Werewolf Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Werewolf Therapeutics's stock was made by Atkins Michael B. on Jan 04 2024, selling - shares at - per share (valued at -). The last insider buy of HOWL was made by RA CAPITAL MANAGEMENT, L.P. on Jan 10 2023, buying 1,853,000 shares at $2.21 per share (worth $4.10M).
Werewolf Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 7 | 1 | 700.00% |
| Q2 2023 | 6 | 1 | 600.00% |
| Q1 2023 | 8 | - | - |
| Q2 2022 | 8 | - | - |
| Q1 2022 | 9 | 2 | 450.00% |
| Q4 2021 | 2 | 3 | 66.67% |
| Q3 2021 | 1 | - | - |
| Q2 2021 | 50 | 40 | 125.00% |
| Q1 2021 | 1 | - | - |
| Q4 2020 | 9 | - | - |
| Q3 2020 | 1 | - | - |
7 total buy trades, and 1 total sell trades (buy/sell ratio of 7.00%) were made by Werewolf Therapeutics's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | 1 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 2 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 15 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 3 | - | - |
| Q3 2020 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Werewolf Therapeutics's stocks.
Werewolf Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. |
| DSGN | Design Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| CYT | Cyteir Therapeutics, Inc. |
| PASG | Passage Bio, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
| TALS | Tourmaline Bio, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| DBTX | Decibel Therapeutics, Inc. |
| VOR | Vor Biopharma Inc. |
| THRD | Third Harmonic Bio, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| ACRV | Acrivon Therapeutics, Inc. Common Stock |
| CGEM | Cullinan Oncology, Inc. |
| CSBR | Champions Oncology, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| IKNA | Ikena Oncology, Inc. |
| MOLN | Molecular Partners AG |
| ACET | Adicet Bio, Inc. |
| MNOV | MediciNova, Inc. |
| CELC | Celcuity Inc. |
HOWL Ownership FAQ
Who Owns Werewolf Therapeutics?
Werewolf Therapeutics is owned by institutional shareholders (88.19%), insiders (6.27%), and public (5.54%). The largest institutional shareholder of Werewolf Therapeutics is RA CAPITAL MANAGEMENT, L.P. (16.80% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.03% of total shares).
Who are the major institutional shareholders of Werewolf Therapeutics?
Werewolf Therapeutics's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, PFM HEALTH SCIENCES, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and BIOIMPACT CAPITAL LLC. The top five shareholders own together 51.47% of the company's share outstanding.
How many Werewolf Therapeutics shareholders are there?
As of Mar 2024, there are 63 institutional shareholders of Werewolf Therapeutics.
What percentage of Werewolf Therapeutics is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 6.14M shares of Werewolf Therapeutics, representing 16.80% of the company's total shares outstanding, valued at $39.82M (as of Mar 2024).
What percentage of Werewolf Therapeutics is owned by MPM ASSET MANAGEMENT LLC?
As of Mar 2024, MPM ASSET MANAGEMENT LLC holds 4.28M shares of Werewolf Therapeutics (HOWL), compromising 11.71% of the company, valued at $27.76M.
What percentage of Werewolf Therapeutics is owned by PFM HEALTH SCIENCES, LP?
PFM HEALTH SCIENCES, LP is the third largest holder of Werewolf Therapeutics. The company owns 3.01M of the company's shares outstanding (worth $19.48M).